BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 23576199)

  • 1. [Diagnostic and predictive analyses of cytological specimens of non-small cell lung cancer: strategies and challenges].
    Herth FJ; Bubendorf L; Gütz S; Morresi-Hauf A; Hummel M; Junker K; Lehmann U; Petersen I; Schnabel PA; Warth A
    Pneumologie; 2013 Apr; 67(4):198-204. PubMed ID: 23576199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue sampling in lung cancer: a review in light of the MERIT experience.
    Reck M; Hermes A; Tan EH; Felip E; Klughammer B; Baselga J
    Lung Cancer; 2011 Oct; 74(1):1-6. PubMed ID: 21658788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of EML4-ALK fusion genes in a few cancer cells from transbronchial cytological specimens utilizing immediate cytology during bronchoscopy.
    Kanaji N; Bandoh S; Ishii T; Tadokoro A; Watanabe N; Takahama T; Haba R; Imataki O; Dobashi H; Matsunaga T
    Lung Cancer; 2012 Aug; 77(2):293-8. PubMed ID: 22494566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tissue is the issue: personalized medicine for non-small cell lung cancer.
    Hirsch FR; Wynes MW; Gandara DR; Bunn PA
    Clin Cancer Res; 2010 Oct; 16(20):4909-11. PubMed ID: 20926402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of oncology treatment through diagnostic testing.
    Oakley G
    MLO Med Lab Obs; 2013 Dec; 45(12):38. PubMed ID: 24409595
    [No Abstract]   [Full Text] [Related]  

  • 6. First-line therapy of mutated non-small cell lung cancer: an update.
    Stöhlmacher-Williams J
    Onkologie; 2012; 35(5):293-9. PubMed ID: 22868512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the pulmonologist in ordering post-procedure molecular markers in non-small-cell lung cancer: implications for personalized medicine.
    Murgu S; Colt H
    Clin Lung Cancer; 2013 Nov; 14(6):609-26. PubMed ID: 24188629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular pathological diagnosis in cytopathology of non-small-cell lung cancer. Standardization of specimen processing].
    Warth A; Bubendorf L; Gütz S; Morresi-Hauf A; Hummel M; Junker K; Lehmann U; Petersen I; Schnabel PA
    Pathologe; 2013 Jul; 34(4):310-7. PubMed ID: 23728235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour tissue sampling for lung cancer management in the era of personalised therapy: what is good enough for molecular testing?
    Kim L; Tsao MS
    Eur Respir J; 2014 Oct; 44(4):1011-22. PubMed ID: 25102961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The surgeon's role in molecular biology.
    Rocco G
    J Thorac Cardiovasc Surg; 2012 Sep; 144(3):S18-22. PubMed ID: 22739075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishing an EGFR mutation screening service for non-small cell lung cancer - sample quality criteria and candidate histological predictors.
    Leary AF; Castro DG; Nicholson AG; Ashley S; Wotherspoon A; O'Brien ME; Popat S
    Eur J Cancer; 2012 Jan; 48(1):61-7. PubMed ID: 22036089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New biomolecular methodologies in diagnosis of lung cancer].
    Carpagnano GE; Palladino GP; Gramiccioni C; Spanevello A; Cagnazzo MG; Barbaro MP
    Recenti Prog Med; 2008 Sep; 99(9):417-21. PubMed ID: 19044249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Personalizing" therapy for non-small cell lung cancer.
    D'Cunha J
    Semin Thorac Cardiovasc Surg; 2010; 22(2):118-20. PubMed ID: 21092888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalized medicine for non-small-cell lung cancer: implications of recent advances in tissue acquisition for molecular and histologic testing.
    Moreira AL; Thornton RH
    Clin Lung Cancer; 2012 Sep; 13(5):334-9. PubMed ID: 22424871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individualized therapy for patients with non-small cell lung cancer: emerging trends and challenges.
    Langer CJ
    Crit Rev Oncol Hematol; 2012 Jul; 83(1):130-44. PubMed ID: 22280915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current and future molecular diagnostics in non-small-cell lung cancer.
    Li CM; Chu WY; Wong DL; Tsang HF; Tsui NB; Chan CM; Xue VW; Siu PM; Yung BY; Chan LW; Wong SC
    Expert Rev Mol Diagn; 2015; 15(8):1061-74. PubMed ID: 26153330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pathology of non-small cell lung cancer: a practical guide.
    Aisner DL; Marshall CB
    Am J Clin Pathol; 2012 Sep; 138(3):332-46. PubMed ID: 22912349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personalized medicine for lung cancer: new challenges for pathology.
    Kerr KM
    Histopathology; 2012 Mar; 60(4):531-46. PubMed ID: 21916947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and predictive molecular analysis of non-small-cell lung cancer in the Africa-Middle East region: challenges and strategies for improvement.
    Slavik T; Asselah F; Fakhruddin N; El Khodary A; Torjman F; Anis E; Quinn M; Khankan A; Kerr KM
    Clin Lung Cancer; 2014 Nov; 15(6):398-404. PubMed ID: 25043210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A reevaluation of the clinical significance of histological subtyping of non--small-cell lung carcinoma: diagnostic algorithms in the era of personalized treatments.
    Rossi G; Pelosi G; Graziano P; Barbareschi M; Papotti M
    Int J Surg Pathol; 2009 Jun; 17(3):206-18. PubMed ID: 19443885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.